Global leadership. Local impact.

The Gillings School's Department of Epidemiology is one of the world’s leading academic departments for epidemiological study. Renowned faculty members empower students with training in effective research practices and methods. We conduct innovative, interdisciplinary research and provide classroom and real-world education that emphasizes the integration of substantive area knowledge with cutting-edge epidemiologic methods. We also work with students to apply their research to a variety of health problems across North Carolina and around the world. As countries around the globe work to slow the spread of the novel coronavirus SARS-CoV-2, researchers and practitioners from every discipline at the UNC Gillings School of Global Public Health are turning their expertise into action to support the pandemic response.

Our Recent News

William R. Kenan, Jr. Distinguished Professor Dr. Ralph S. Baric is a world leader in coronavirus research and is part of a research collaboration between Duke University and University of North Carolina at Chapel Hill that has identified and tested a new antibody that limits the severity of infections from COVID-19 as well as the original SARS illness.

Dr. Ralph Baric (Jon Gardiner/UNC-Chapel Hill)
Ralph S. Baric, PhD

Coronavirus Affects Everyone: The Department of Epidemiology Responds

Drs. Ralph Baric, Timothy Sheahan, Lisa Gralinski and many others in the Baric Lab are racing to find answers to COVID-19. Dr. Baric also is working with the Vaccine Research Center at the National Institutes of Health to evaluate lead candidate vaccines; additionally, he serves on the WHO and Coalition for Epidemic Preparedness Innovations working groups, which are seeking countermeasures against the novel coronavirus.

Dr. Allison Aiello served as a member of the WHO Working Group on public health measures for mitigating the risk and impact of influenza, which now serves as a source for guidance on public health measures for COVID-19 (PDF). One of her research papers on schools closings was mentioned in a recent New York Times opinion piece that discusses the importance of timing during epidemics.

Dr. Andy Olshan organized a March 3 coronavirus seminar to share what experts knew about the outbreaks at that point.

Dr. Kim Powers, who models infectious diseases in populations, recently gave an interview on why the exponential growth of COVID-19 makes containment more challenging and is helping the North Carolina Department of Health and Human Services (NCDHHS) with projections of the COVID-19 trajectory in the state.

Dr. Jim Thomas is the lead author of the American Public Health Association’s code of ethics — a document that balances the value of individual independence against societal interdependence when it comes to public health. He recently has spoken to Quartz and the BMJ Global Health Blog about ethical pandemic control and the need for social distancing.

Dr. David Weber is in charge of infection prevention efforts at UNC Hospitals and has spoken about emergency scenario planning for health care teams.

An illustration from the Centers for Disease Control and Prevention reveals the basic form of the virus blamed for the outbreak of respiratory illness first detected in Wuhan, China.

Message from the Chair

Coronavirus drug shows promise at Carolina

UNC Gillings School of Global Public Health researchers are testing a new broad-spectrum antiviral drug that could potentially be a relief to the global coronavirus pandemic.

Watch the video
			

Second Annual SARS-CoV-2 and COVID-19 Updates Seminar (March, 2021)

Leading experts from the Department of Epidemiology at the UNC Gillings School of Global Public Health share the latest on new COVID-19 variants, vaccines and vaccine trials, breakthrough treatments, what’s happening in the clinical environment, Centers for Disease Control and Prevention (CDC) perspectives and much more.

Watch the video